Page 4 - Karen Aiach News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Karen aiach. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Karen Aiach Today - Breaking & Trending Today

FDA Grants Lysogene Fast Track Designation for GM1 Gangliosidosis Gene Therapy

FDA Grants Lysogene Fast Track Designation for GM1 Gangliosidosis Gene Therapy
globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.

United States , Karen Aiach , Drug Administration , Lysogene Fast Track , ஒன்றுபட்டது மாநிலங்களில் ,

LYSOGENE Releases the Results From June 25, 2021 Ordinary Annual and Extraordinary General Meeting

LYSOGENE Releases the Results From June 25, 2021 Ordinary Annual and Extraordinary General Meeting
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Karen Aiach , Sarepta Therapeutics Inc , Chief Executive Officer , Sarepta Therapeutics , Looking Statement , French Autorit , Des March , French Markets Authorities , Durant Des Aulnois , Financial Officer , ஒன்றுபட்டது மாநிலங்களில் , சாறெப்டா சிகிச்சை இன்க் , தலைமை நிர்வாகி அதிகாரி , சாறெப்டா சிகிச்சை , பார்க்கிறது அறிக்கை , தேஸ் அணிவகுப்பு , பிரஞ்சு சந்தைகள் அதிகாரிகள் , நிதி அதிகாரி ,

Little girl travels to Manchester from Russia to become first child in the world to receive pioneering gene therapy

Little girl travels to Manchester from Russia to become first child in the world to receive pioneering gene therapy
manchestereveningnews.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from manchestereveningnews.co.uk Daily Mail and Mail on Sunday newspapers.

United Kingdom , Simon Jones , Karen Aiach , Manchester University , Royal Manchester Children , Saint Mary , ஒன்றுபட்டது கிஂக்டம் , சிமோன் ஜோன்ஸ் , மான்செஸ்டர் பல்கலைக்கழகம் , அரச மான்செஸ்டர் குழந்தைகள் , துறவி மேரி ,

Lysogene Announces First Patient Dosed with LYS-GM101 Investigational Gene Therapy for the Treatment of GM1 Gangliosidosis

Lysogene Announces First Patient Dosed with LYS-GM101 Investigational Gene Therapy for the Treatment of GM1 Gangliosidosis
Ongoing enrollment of a total of 16 patients in the UK, US and France
Regulatory News:
Lysogene (Paris:LYS) (FR0013233475 LYS), a phase 3 gene therapy platform company targeting central nervous system (CNS) diseases, today announced dosing of the first patient, at Royal Manchester Children s Hospital, part of Manchester University NHS Foundation Trust, in the global adaptative-design clinical trial with LYS-GM101 (NCT04273269), a gene therapy for the treatment of GM1 gangliosidosis.
This trial is an interventional, multi-center, single-arm, two-stage adaptive-design study evaluating the intracisternal delivery of a recombinant adeno-associated virus vector serotype rh.10 (AAVrh.10) carrying the human ß-galactosidase gene (GBL1). The clinical trial includes a safety phase and a confirmatory efficacy phase. The trial will enroll 16 patients wi ....

United Kingdom , United States , Simon Jones , Karen Aiach , Manchester University , European Union , University Of Manchester , University Dental Hospital Of Manchester , Sarepta Therapeutics Inc , Foundation Trust , Second Lysogene , Royal Manchester Children , Founder Chairman , Chief Executive Officer , Chief Investigator , Paediatric Inherited Metabolic Disease , Senior Lecturer , Rare Pediatric Disease , Casimir Trials , Sarepta Therapeutics , Manchester Royal Infirmary , Saint Mary , Manchester Royal Eye Hospital , University Dental Hospital , Trafford General , Altrincham Hospital ,

Lysogene Announces a Change in the Organization of KGA, Minority Shareholder of Lysogene

Lysogene Announces a Change in the Organization of KGA, Minority Shareholder of Lysogene
Regulatory News:
Lysogene (Paris:LYS) (FR0013233475 LYS), a phase 3 gene therapy platform Company targeting central nervous system (CNS) diseases, announces a change in the governance and control of KGA, a company co-owned by Karen Aiach and which currently owns approximately 6% of Lysogene s capital.
As part of a reorganization of her personal assets, Karen Aiach, founder and Chief Executive Officer of Lysogene, has resigned from her position as Chairman of KGA and sold some of her shares in KGA, which she consequently no longer jointly controls.
These changes are in response to personal considerations, not specific to the stake held in Lysogene. Moreover, they have no impact on the interest that Karen Aiach holds directly in the capital of Lysogene. ....

United States , Karen Aiach , Sarepta Therapeutics Inc , Regulatory News , Chief Executive Officer , Sarepta Therapeutics , Looking Statement , French Autorit , Des March , French Markets Authorities , Durant Des Aulnois , Financial Officer , ஒன்றுபட்டது மாநிலங்களில் , சாறெப்டா சிகிச்சை இன்க் , ஒழுங்குமுறை செய்தி , தலைமை நிர்வாகி அதிகாரி , சாறெப்டா சிகிச்சை , பார்க்கிறது அறிக்கை , தேஸ் அணிவகுப்பு , பிரஞ்சு சந்தைகள் அதிகாரிகள் , நிதி அதிகாரி ,